Efficacy of preemptive analgesia on acute postoperative pain in children undergoing major orthopedic surgery of the lower extremities by 源��궓�삤 et al.
© 2018 Kim et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. 
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work 
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Journal of Pain Research  2018:11 2061–2070
Journal of Pain Research Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
2061
O R i g i n a l  R e s e a R c h
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/JPR.S175169
Efficacy of preemptive analgesia on acute 
postoperative pain in children undergoing major 
orthopedic surgery of the lower extremities
Do-Hyeong Kim
Namo Kim
Jae hoon lee
Minju Jo
Yong Seon Choi
Department of Anesthesiology and 
Pain Medicine, Anesthesia and Pain 
Research Institute, Yonsei University 
College of Medicine, Seoul, Republic 
of Korea
Background: Children undergoing major orthopedic surgery of the lower extremities can 
experience severe postoperative pain; yet, the ideal postoperative pain management strategy is 
unknown. Thus, in this patient population, we investigated the effect of intraoperative epidural 
infusion of local anesthetic on acute postoperative pain and analgesic consumption.
Patients and methods: Patients (N=50, 3–12 years) randomly received either ropivacaine 
0.15% (preemptive group) or normal saline (control group) as an initial bolus of 0.2 mL/kg, 
followed by continuous infusion of 0.15 mL/kg/h throughout surgery. Following surgery, patient-
controlled epidural analgesia with ropivacaine 0.1% was provided. The main study outcomes 
were the revised Face, Legs, Activity, Cry, and Consolability pain scores, epidural ropivacaine 
consumption, and additional analgesic requirements during the first 48 hours postoperatively.
Results: Forty-seven patients completed the study, 23 in the preemptive group and 24 in the 
control group, respectively. The revised Face, Legs, Activity, Cry, and Consolability pain scores 
were significantly lower in the preemptive group only at 30 minutes after postanesthesia care 
unit arrival and 6 hours after surgery (median difference –1.0, 95% CI –2.0 to –1.0, P=0.001 
and median difference –2.0, 95% CI –3.0 to –1.0, P=0.005, respectively). However, they were 
not significantly different between the groups at 12, 24, and 48 hours postoperatively. Epidural 
ropivacaine consumption and additional analgesic requirements throughout 48 hours postop-
eratively were not significantly different between the groups.
Conclusion: Intraoperative epidural infusion of ropivacaine did not demonstrate preemptive 
analgesic efficacy within 48 hours postoperatively in children undergoing extensive lower limb 
orthopedic surgery.
Keywords: epidural analgesia, postoperative analgesia, orthopedics, pediatrics
Introduction
Children with musculoskeletal pathology often require extensive surgical interven-
tions to correct deformities and improve function. Such extensive surgery renders 
significant tissue damage and intense postoperative pain.1 Inadequate treatment of 
postoperative pain can lead to poor outcomes; thus, postoperative pain management 
is an essential part of perioperative care in pediatric patients undergoing orthopedic 
surgery.2,3 However, the optimal strategy for postoperative pain management in this 
patient population is unknown.
One potential strategy is preemptive analgesia. This intervention is designed 
to reduce acute postoperative pain and minimize the development of chronic pain 
conditions. Preemptive analgesia prevents central sensitization by interrupting 
the transmission of the peripheral afferent nociceptive barrage to the spinal cord.4 
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Although numerous experimental studies have demonstrated 
the efficacy of preemptive analgesia on postoperative pain, 
results of clinical studies are controversial.4,5 For example, 
unlike in the study using local anesthetic only for epidural 
infusion, no difference in postoperative pain relief between 
presurgical and postsurgical continuous epidural analgesia 
was observed in the study using local anesthetic and mor-
phine mixture for epidural infusion.6,7 This could be because 
the use of morphine, which has a sedative effect, masked any 
preemptive analgesic effects. In addition, these conflicting 
results may result from variations in the relative timing of 
treatment initiation,4,8 or from incomplete afferent blockade 
using systemic analgesics or local anesthetics.9
In children undergoing extensive lower limb orthopedic 
surgery, postoperative epidural analgesia is beneficial.10 For 
these patients, considering that pathological changes that 
could aggravate acute pain and contribute to pain chronicity 
occur in the central nervous system, preemptive analgesia 
including intraoperative epidural infusion of local anesthetic 
may sufficiently protect the central nervous system from 
nociceptive input throughout surgery and subsequently 
reduce postoperative pain.8 Previously, Ong et al reported that 
preemptive epidural analgesia improves acute postoperative 
pain;11 however, the effect of preemptive epidural analgesia 
on acute postoperative pain in pediatric orthopedic surgery 
is unknown.
Thus, the primary aim of this study was to evaluate 
whether intraoperative epidural infusion of local anesthetic 
would improve acute postoperative pain in pediatric patients 
undergoing major orthopedic surgery of the lower extremi-
ties. We also investigated postoperative analgesic consump-
tion, including epidurally administered local anesthetic and 
systemic analgesics.
Patients and methods
The study protocol was approved by the institutional review 
board of the Yonsei University Health System, Seoul, South 
Korea (#4-2016-0322) and registered at ClinicalTrials.gov 
(NCT02813018). After receiving written informed consent 
from the parents or legal guardians, we enrolled 50 patients 
(range, 3–12 years) who were scheduled to undergo single-
event multilevel surgery that included at least one bony 
surgical procedure and/or reconstructive hip surgery for gait 
improvement between July 2016 and July 2017. Exclusion 
criteria were as follows: 1) known or suspected coagulopathy, 
2) congenital anomalies or signs of infection at the site of the 
proposed epidural block, 3) allergy to the study drugs, and 
4) severe-profound cognitive impairment. Enrolled patients 
were randomized to receive intraoperative epidural infusion 
of either ropivacaine 0.15% (preemptive group) or normal 
saline (control group). Randomization was performed using 
a computer-generated randomization sequence (http://www.
randomizer.org) by an investigator not involved in patient 
care or perioperative assessment. Allocation results were 
concealed in sealed opaque envelopes that were given to 
an anesthesia nurse not involved with the study. The nurse 
prepared ropivacaine 0.15% or normal saline in identical 
syringes under sterile conditions according to the allocation. 
Consequently, the surgeons, attending anesthesiologists, 
investigators, nursing staff, and patients’ parents were blinded 
to the group assignment throughout the study.
Intraoperative management
No premedication was administered. Upon arrival to the 
operating room, standard monitoring and measurement of 
the bispectral index were initiated. Anesthesia was induced 
with propofol 1.0–2.0 mg/kg and fentanyl 1.0 µg/kg, fol-
lowed by rocuronium 0.6 mg/kg for muscle relaxation to 
facilitate tracheal intubation. A radial artery catheter was 
then placed for continuous arterial pressure monitoring. 
Anesthesia was maintained with sevoflurane at a 0.7–1.5 age-
adjusted minimum alveolar concentration in a 50% oxygen–
air mixture, with a target bispectral index between 40 and 
60. Sevoflurane was adjusted to maintain the mean arterial 
pressure (MAP) and heart rate (HR) within 80%–120% of 
preoperative values. Controlled ventilation was performed 
to maintain an end-tidal carbon dioxide tension of 35–40 
mmHg. Hypotension (MAP <80% of baseline) persisting 
for 5 minutes was treated with normal saline boluses and, 
if required, ephedrine or phenylephrine. Bradycardia (HR 
<60 beats/min) was treated with atropine. After surgery and 
cast application, neuromuscular blockade was antagonized 
with neostigmine and glycopyrrolate, and the trachea was 
extubated when patients were fully awake and breathing 
adequately. All patients were transferred to the postanes-
thesia care unit (PACU).
Intervention
After tracheal intubation, patients were placed in the lateral 
decubitus position. An 18-gauge Tuohy needle was inserted 
at the L3–4 or L4–5 interspace using the midline approach. A 
20-gauge epidural catheter was advanced up to 3 cm cephalad 
into the epidural space, which was identified by the loss-of-
resistance-to-saline technique. The catheter was aspirated to 
exclude intravenous or intrathecal placement, and after secur-
ing the catheter, patients were returned to the supine position 
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for surgical preparation. Patients then received a bolus of 0.2 
mL/kg of the prepared solution (ropivacaine 0.15% or nor-
mal saline) through the catheter, and the same solution was 
infused at a rate of 0.15 mL/kg/h using a syringe pump 15 
minutes before skin incision until the end of the surgery. The 
mean duration of infusion was 301.6 minutes. The maximum 
intraoperative infusion rate in patients exceeding 30 kg was 
4.5 mL/h. The mean operation time was 286.6 minutes. At 
the end of surgery, epidural infusion was stopped, followed 
by the same epidural patient-controlled analgesia (PCA). The 
PCA device containing ropivacaine 0.1% in normal saline 
solution with a total volume of 9 mL/kg delivered a 0.05 mL/
kg/h background infusion and 0.1 mL/kg on-demand boluses 
with a 30-minute lockout time. Then, the PCA device bolus 
button was pushed once, and intravenous fentanyl 1.0 µg/
kg was injected. Immediately after PACU arrival, the bolus 
button was pushed once more. The PCA was accessible for 
48 hours postoperatively.
Postoperative management and 
patient assessments
Postoperative pain was assessed using the revised Face, Legs, 
Activity, Cry, and Consolability (r-FLACC) pain scale.12 This 
scale consists of five subgroups (face, legs, activity, cry, and 
consolability) for which the child can be assigned 0, 1, or 2 
points related to specific pain reactions, and an overall score 
of 7–10 indicates severe pain or discomfort. Preoperatively, 
the parents or primary caregivers completed a questionnaire 
regarding the individual pain behavior of the child related to 
each r-FLACC subgroup, and these answers were added. In 
the PACU, rescue analgesics (intravenous fentanyl 0.5 µg/
kg) were administered when the r-FLACC score was >4. If 
severe nausea or vomiting occurred, the patient was treated 
with metoclopramide 0.2 mg/kg. Epidural analgesia was 
considered successful if the r-FLACC score was ≤3 when 
departing the PACU. In the ward, patients continued to receive 
the epidural PCA and as a supplement, all patients were 
prescribed ibuprofen 5–7 mg/kg per os three times per day 
to maintain an r-FLACC score ≤4. However, if the r-FLACC 
score was persistently >4 or on parents’ request, rescue 
intravenous tramadol 1 mg/kg was given. If severe nausea or 
vomiting occurred, we treated patients with 0.2 mg/kg meto-
clopramide. If dizziness, urinary retention, or intense motor 
blockade occurred, PCA was stopped temporarily. The PCA 
restarted only after these symptoms had been resolved. If the 
block was clinically inadequate or the epidural catheter was 
inadvertently dislodged, the patient was withdrawn from the 
study, and fentanyl-based intravenous PCA was prescribed.
Postoperative r-FLACC pain scores were our primary 
outcome. Scores were assessed 30 minutes after arrival at the 
PACU and 6, 12, 24, and 48 hours postoperatively. Second-
ary outcomes included analgesic consumption and adverse 
events. To assess epidural ropivacaine consumption, the 
amounts of epidural ropivacaine given as boluses and boluses 
plus background infusion, respectively, were recorded during 
0–6, 6–12, 6–24, and 24–48 hours postoperatively. Cumula-
tive doses of ropivacaine given as boluses and boluses plus 
background infusion, respectively, were also recorded at 6, 
12, 24, and 48 hours postoperatively. Finally, we recorded 
both the numbers of patients requiring additional rescue 
analgesics and the amounts of rescue analgesics used dur-
ing 0–6, 6–12, 12–24, and 24–48 hours postoperatively. The 
consumption of fentanyl and tramadol was converted to intra-
venous morphine equivalents using the GlobalRPh morphine 
equivalence calculator assuming no cross-tolerance, accessed 
at http://globalrph.com/medcalcs/opioid-conversions-calc-
original-single-agent. Adverse events such as postoperative 
nausea and vomiting, urinary retention, and motor blockade 
were recorded. The following perioperative data were also 
collected: MAP and HR (5 minutes after intubation [base-
line], 5 minutes after skin incision, 1 hour after skin incision, 
immediately after skin closure, immediately after extubation, 
and 30 minutes after PACU admission), intraoperative blood 
loss, anesthesia time, and length of PACU stay. An investi-
gator blinded to the group allocation collected all outcomes 
and perioperative data.
Statistical analysis
Distribution normality was assessed using Kolmogorov–
Smirnov and Shapiro–Wilk tests. Continuous variables were 
expressed as mean±SD if data were normally distributed and 
median (interquartile range) if not. Categorical variables were 
expressed as absolute number (%). Groups were compared 
on normally distributed data with an independent t-test, non-
normally distributed data with the Mann–Whiney U test, and 
categorical variables with the chi-squared test or Fisher’s 
exact test. The effects of preemptive epidural analgesia on 
both r-FLACC pain scores and the amount of rescue analge-
sics used were each assessed using a nonparametric mixed 
model provided by Brunner and Langer.13 Group differences 
in the amounts of epidural ropivacaine given as boluses and 
boluses plus background infusion, respectively, were assessed 
using a linear mixed model with patient indicator as a ran-
dom effect and group, time, and group-by-time interaction 
as fixed effects. Group differences in cumulative doses of 
ropivacaine given as boluses and boluses plus background 
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infusion, respectively, were similarly assessed using a linear 
mixed model. This method was also used to assess group dif-
ferences in MAP and HR. These linear mixed model analyses 
used an unstructured covariance structure. The numbers of 
patients requiring additional rescue analgesics were com-
pared between groups using a generalized estimation equa-
tion. P-values were corrected with Bonferroni methods for 
multiple comparisons.
Sample size was estimated based on previous data from 
our hospital, reporting a 1.7 SD for r-FLACC scores 12 
hours postoperatively in this patient population.14 Assuming 
α=0.05 and β=0.15 for a 1.5-point difference in the r-FLACC 
scores between groups, the calculated sample size was 23 
patients per group. To allow for a 10% dropout rate, the ideal 
sample size was 25 patients per group. All statistical analyses 
were performed using SPSS (version 20; IBM Corporation, 
Armonk, NY, USA) and SAS (version 9.2; SAS Institute 
Inc., Cary, NC, USA). A P-value <0.05 was considered 
statistically significant.
Results
Of the 61 patients assessed for eligibility, 11 were excluded 
due to age criteria (n=5), current regular use of analgesics 
(n=1), severe-profound cognitive impairment (n=1), and 
refusal to participate (n=4). Thus, 50 subjects were enrolled. 
Three were excluded from the analysis due to persistent 
motor and sensory block (n=1, preemptive group), change 
of operation plan (n=1, preemptive group), and unexpected 
intensive care unit admission (n=1, control group). Therefore, 
47 patients were included in the final analysis (Figure 1). 
Patient characteristics and perioperative details were not 
significantly different between groups (Table 1).
Postoperative r-FLACC pain scores are demonstrated in 
Table 2. For r-FLACC pain scores, the group-by-time interac-
tion was significant (P=0.035). They were significantly lower 
in the preemptive group at 30 minutes after PACU arrival 
and 6 hours postoperatively (median difference –1.0, 95% 
CI –2.0 to –1.0, P=0.001 and median difference –2.0, 95% 
CI –3.0 to –1.0, P=0.005, respectively). However, they were 
not significantly different in both groups at 12, 24, and 48 
hours postoperatively (median difference 0.0, 95% CI –1.0 
to 0.0, P>0.999; median difference –1.0, 95% CI –1.0 to 0.0, 
P=0.692; and median difference –1.0, 95% CI –1.0 to 0.0, 
P=0.351, respectively).
Throughout 48 hours postoperatively, there were no 
group-by-time interactions for the amounts of epidural 
Figure 1 Flow diagram of patient selection.
Abbreviation: ICU, intensive care unit.
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the  cumulative doses of ropivacaine given as boluses and 
boluses plus background infusion did not significantly dif-
fer between groups (P=0.804 and P=0.816, respectively). 
The numbers of patients requiring additional rescue 
analgesics and the amounts of rescue analgesics in terms 
of equianalgesic doses of morphine (mg) were also not 
significantly different between groups over time (P=0.380 
and P=0.261, respectively).
The change of MAP and HR from baseline for both 
groups was consistent over time (P=0.144 and P=0.087, 
respectively; Figure 2). However, comparing within groups 
at each time point revealed that HR was significantly lower 
in the preemptive group than in the control group throughout 
intraoperative epidural infusion. There were no significant 
differences in the incidence of adverse events between the 
two groups (Table 4).
Table 1 Patient characteristics and perioperative details
Preemptive (n=23) Control (n=24) P-value
Female 12 (52.2) 12 (50.0) 0.882
Age (years) 10.0±1.7 9.3±2.5 0.300
Height (cm) 133.4±14.8 128.7±18.4 0.370
Weight (kg) 31.1±9.4 29.5±11.1 0.606
BMI (kg/m2) 17.1±3.0 17.3±3.9 0.858
Previous surgery on the lower limbs 9 (39.1) 8 (33.3) 0.679
Diagnosis >0.999
Cerebral palsy 21 (91.3) 21 (87.5)
Others 2 (8.7) 3 (12.5)
Surgical procedure (n=46 legs) (n=48 legs) 0.447
Pelvic osteotomy 11 (24.1) 15 (31.3)
Femur osteotomya 32 (69.6) 37 (77.1)
Tibial osteotomy 5 (10.9) 9 (18.8)
Foot bony procedure 10 (21.7) 6 (12.5)
Capsulotomy of hip 1 (2.2) 1 (2.1)
Open reduction of hip dislocation 5 (10.9) 8 (16.7)
Epiphysiodesis (femur or tibia tuberosity) 9 (19.6) 11 (22.9)
Psoas lengthening 11 (23.9) 4 (8.3)
Rectus femoris tenotomy 1 (2.2) 0 (0.0)
Adductor tenotomy 14 (30.4) 26 (54.2)
Medial hamstring lengthening 5 (10.9) 10 (20.8)
Patella tendon advancement 16 (34.8) 17 (35.4)
Tibialis anterior transfer 2 (4.3) 1 (2.1)
Tibialis posterior interventions 3 (6.5) 1 (2.1)
Calf muscle lengthening 10 (21.7) 14 (29.2)
Tendon achilles lengthening 10 (21.7) 5 (10.4)
Foot tendon interventions 7 (15.2) 9 (18.8)
Amount of intraoperative ropivacaine (mg/kg) 1.01±0.3 – –
Intraoperative blood loss (mL) 200.0 (100.0–350.0) 250.0 (200.0–387.5) 0.198
Total dose of ephedrine (mg) 0.0 (0.0–4.0) 0.0 (0.0–1.8) 0.520
Total dose of phenylephrine (μg) 0.0 (0.0–250.0) 0.0 (0.0–350.0) 0.861
Operation time (minutes) 269.3±92.6 303.3±126.0 0.299
Anesthesia time (minutes) 334.8±102.6 367.3±120.3 0.325
Length of PACU stay (minutes) 45.0 (40.0–50.0) 40.0 (40.0–50.0) 0.440
Notes: Data are presented as mean±SD, median (interquartile range), or number of patients (%). aFemur osteotomy: femoral derotational osteotomy, femoral varization-
derotational osteotomy, or distal femoral extension and shortening osteotomy.
Abbreviation: PACU, postanesthesia care unit.
Table 2 Postoperative pain scores determined using the 
r-Flacc pain scale
Preemptive 
(n=23)
Control 
(n=24)
Median  
difference  
(95% CI)
P-value
r-Flacc 0.035a
PACU 0.0 (0.0–1.0) 1.5 (1.0–2.5) –1.0 (–2.0 to –1.0) 0.001
6 hours 1.0 (0.0–2.0) 3.0 (2.0–4.0) –2.0 (–3.0 to –1.0) 0.005
12 hours 1.0 (1.0–3.0) 2.0 (1.0–3.0)  0.0 (–1.0 to 0.0) >0.999
24 hours 1.0 (0.0–2.0) 2.0 (1.0–3.0) –1.0 (–1.0 to 0.0) 0.692
48 hours 0.0 (0.0–1.0) 1.0 (0.5–2.0) –1.0 (–1.0 to 0.0) 0.351
Notes: Data are presented as median (interquartile range). aP-value of the group-
by-time interaction in the nonparametric mixed model.
Abbreviations: PACU, postanesthesia care unit; r-FLACC, revised Face, Legs, 
Activity, Cry, and Consolability.
ropivacaine given as boluses and boluses plus back-
ground infusion (P=0.781 and P=0.892, respectively; 
Table 3). Similarly, when all time points were combined, 
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Table 3 Consumption of epidural ropivacaine by patient-controlled analgesia and additional analgesic requirements
Preemptive (n=23) Control (n=24) Mean or median  
difference (95% CI)
P-value
Amount of ropivacaine given as boluses (mg/kg/h) 0.781a
 0–6 hours 0.07±0.03 0.08±0.04 –0.02 (–0.04 to 0.01) 0.512
 6–12 hours 0.05±0.05 0.07±0.04 –0.01 (–0.04 to 0.01) >0.999
 12–24 hours 0.07±0.04 0.08±0.04 –0.01 (–0.03 to 0.01) >0.999
 24–48 hours 0.05±0.04 0.06±0.04 –0.00 (–0.03 to 0.02) >0.999
Amount of ropivacaine given as boluses plus background infusion (mg/kg/h) 0.892a
 0–6 hours 0.12±0.03 0.13±0.04 –0.02 (–0.04 to –0.01) 0.582
 6–12 hours 0.10±0.05 0.12±0.04 –0.01 (–0.04 to 0.01) >0.999
 12–24 hours 0.12±0.04 0.12±0.04 –0.01 (–0.03 to 0.01) >0.999
 24–48 hours 0.10±0.04 0.11±0.04 –0.01 (–0.03 to 0.02) >0.999
Cumulative dose of ropivacaine given as boluses (mg/kg) 0.804a
 ~6 hours 0.48±0.23 0.59±0.27 –0.11 (–0.26 to 0.04) 0.566
 ~12 hours 0.80±0.47 0.98±0.45 –0.18 (–0.45 to 0.09) 0.732
 ~24 hours 1.60±0.93 1.90±0.78 –0.30 (–0.81 to 0.20) 0.928
 ~48 hours 2.84±1.63 3.24±1.37 –0.40 (–1.28 to 0.49) >0.999
Cumulative dose of ropivacaine given as boluses plus background infusion (mg/kg) 0.816a
 ~6 hours 0.83±0.23 0.93±0.27 –0.10 (–0.25 to 0.05) 0.693
 ~12 hours 1.45±0.48 1.63±0.45 –0.18 (–0.45 to 0.10) 0.822
 ~24 hours 2.85±0.94 3.14±0.78 –0.29 (–0.80 to 0.22) >0.999
 ~48 hours 5.24±1.66 5.66±1.37 –0.42 (–1.31 to 0.47) >0.999
Patients receiving rescue analgesics 0.380b
 0–6 hours 4 (17.4) 7 (29.1) – >0.999
 6–12 hours 10 (43.5) 9 (37.5) – >0.999
 12–24 hours 12 (52.2) 10 (41.7) – >0.999
 24–48 hours 10 (43.5) 12 (50.0) – >0.999
Amount of rescue analgesics converted into equianalgesic doses of morphine (mg) 0.261c
 0–6 hours 0.00 (0.00–0.00) 0.00 (0.00–0.03) 0.00 (0.00–0.00) >0.999
 6–12 hours 0.00 (0.00–0.03) 0.00 (0.00–0.03) 0.00 (0.00–0.00) >0.999
 12–24 hours 0.03 (0.00–0.03) 0.00 (0.00–0.03) 0.00 (0.00–0.03) >0.999
 24–48 hours 0.00 (0.00–0.03) 0.02 (0.00–0.03) 0.00 (–0.03 to 0.00) >0.999
Notes: Data are presented as mean±SD, median (interquartile range), or number of patients (%). aP-value of the group-by-time interaction in the linear mixed model. bP-
value of the group-by-time interaction in the analysis using generalized estimation equation. cP-value of the group-by-time interaction in the nonparametric mixed model.
Discussion
This study demonstrated that in this patient population, 
intraoperative epidural ropivacaine infusion significantly 
lowered pain scores relative to saline treatment only 
up to 6 hours postoperatively, but not at 12, 24, and 48 
hours postoperatively. Additionally, epidural ropivacaine 
 consumption and additional analgesic requirements dur-
ing postoperative 48 hours were not significantly different 
between the groups.
Pediatric patients undergoing extensive lower limb 
orthopedic surgery experience frequent and severe pain 
postoperatively.1 Although animal studies on preemptive 
analgesic efficacy yielded promising results,4 clinical 
research on this subject in pediatric patients is limited. In a 
recent study, Song et al reported that for pediatric patients 
undergoing corrective osteotomy, preemptive analgesia 
using intravenous PCA with fentanyl did not significantly 
affect postoperative pain.15 However, this study had two key 
limitations that may explain these negative results. First, 
they compared the effects of PCA when initiated either 
just before or after skin incision, conforming to the classic 
view of preemptive analgesia. Second, they used a systemic 
opioid, which may not sufficiently block nociceptive input 
to prevent central sensitization.16
Preventive analgesia, a broader approach than the 
restrictive definition of preemptive analgesia, minimizes 
sensitization induced by noxious perioperative stimuli, 
including those arising preoperatively, intraoperatively, and 
postoperatively.8,17 Considering that multiple skin incisions 
and/or osteotomy during single-event multilevel surgery 
could produce strong and continuous nociceptive input, this 
broader approach, especially focused on the intraoperative 
period, could be more effective than antinociceptive proce-
dures implemented only preoperatively.18 Additionally, in a 
previous study comparing the effects of epidural anesthesia 
alone, general anesthesia, or combined epidural and general 
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anesthesia on postoperative pain and analgesia in patients 
undergoing radical prostatectomy, improved postoperative 
analgesia was observed in patients with epidural anesthesia 
alone.19 This suggests that epidural intraoperative  analgesics 
can sufficiently block nociceptive inputs. However, in 
previous reports on the efficacy of epidural analgesia for 
postoperative pain control in children undergoing major 
orthopedic surgery of the lower extremities, local anesthetic 
Figure 2 Perioperative hemodynamic variables.
Notes: (A) Mean arterial pressure did not significantly differ between treatment groups at any time point. (B) Heart rate was significantly lower for the preemptive treatment 
group relative to control group between T1 and T3. All values are mean±sD. *P<0.05 vs control group. T0, 5 minutes after intubation (baseline); T1, 5 minutes after skin 
incision; T2, 1 hour after skin incision; T3, immediately after skin closure; T4, immediately after extubation; T5, 30 minutes after postanesthesia care unit admission.
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infusion was started 1 hour before the end of the anesthesia 
or postoperative period.1,10,20
Thus, the authors tested whether intraoperative epidural 
infusion of ropivacaine could alleviate acute postopera-
tive pain in pediatric patients undergoing extensive lower 
limb orthopedic surgery. This treatment only significantly 
lowered pain scores within the first 6 hours postopera-
tively, and otherwise did not significantly affect analgesic 
outcomes. According to Katz et al, preventive analgesia 
occurs when postoperative pain is still reduced after the 
duration of action of the target drug, or after 5.5 half-lives 
of the target drug.8 Based on previous reports, we esti-
mate that at the concentration and volume administered 
in this study, the half-life of ropivacaine is ~3 hours.21–24 
Therefore, our study outcomes may result from the direct 
analgesic effect of intraoperative epidural infusion and not 
preemptive analgesia.
There are many possible explanations for the lack of pre-
emptive analgesic efficacy in this study. First, intraoperative 
epidural infusion of ropivacaine may not sufficiently block 
the overwhelming nociceptive input. Importantly, favorable 
effects of preemptive analgesia have been reported in adult 
patients undergoing radical prostatectomy when there was 
sufficient epidural anesthesia, which was verified by mea-
suring the sensory level before general anesthesia induction 
and in the PACU.25 In that study, patients who did not have 
a T4 sensory level were excluded. In the present study, the 
epidural catheter was placed following anesthetic induction, 
and the cast was applied after surgery (eg, spica cast). Thus, 
it was not possible to precisely assess the sensory blockade 
of intraoperative epidural infusion in the PACU. However, 
the epidural infusion regimen in this study was modified 
according to the epidural analgesia protocol for children in 
our hospital. The concentration and volume of epidural ropi-
vacaine for children were based on several references.3,14,22 
In addition, as HR was significantly higher in the control 
group than in the preemptive group throughout intraopera-
tive epidural infusion, there was enough blockade to prevent 
pain-induced increases in sympathetic tone. Importantly, 
excessive blockade of spinal nociception could impede the 
detection of critical side effects of extensive lower limb 
orthopedic surgery, such as nerve injury or compartment 
syndrome. Thus, we could not intraoperatively infuse high 
doses of ropivacaine while expecting only preemptive anal-
gesia. Therefore, our results do not disapprove preemptive 
analgesia itself, but signify that intraoperative epidural 
infusion of local anesthetic alone does not achieve effective 
preemptive analgesia in this patient population. Second, the 
combination of surgical procedures that the patients under-
went varied greatly. Despite this inter-individual variability, 
surgical procedure details were not statistically different 
between groups (Table 1). Additionally, we assumed that 
the regimen of intraoperative epidural infusion produced 
sensory blockade up to the T12 level, which covers most 
of the surgical site. Third, our study did not consider the 
extent to which postoperative peripheral nociceptive inputs 
contribute to central sensitization and postoperative pain. 
Gordon et al demonstrated that in patients undergoing third 
molar extraction surgery, the peripheral nociceptive barrage 
occurring after the surgery contributes to central sensitiza-
tion more extensively than the nociceptive barrage occurring 
intraoperatively.26 In Kjeldgaard Pedersen et al’s study, which 
tested the efficacy of epidural analgesia and local infiltration 
analgesia for early postoperative pain control in children 
undergoing unilateral hip reconstruction, the patients of the 
epidural group received continuous epidural infusion of local 
anesthetic during the anesthesia, which was maintained for 
the first 2–3 days postoperatively.27 Although direct compari-
son is not possible, the postoperative r-FLACC pain scores 
in this study were rather slightly lower than in Kjeldgaard 
Pedersen et al’s study. Further controlled studies will be 
needed focusing on this issue.
Limitations
Our study had a few limitations. First, we used epidural PCA 
with a background infusion, which might affect postopera-
tive outcomes. However, the background infusion rate of 
0.05 mg/kg/h was considerably lower than the postoperative 
epidural ropivacaine infusion rate recommended to chil-
dren over 6 months.24,28 Second, intravenous fentanyl was 
administered during the intraoperative period. However, 
the same dose of fentanyl was used in both groups, and the 
likelihood of opioid-induced hyperalgesia from 2.0 µg/kg 
fentanyl is slight.29
Overall, our results reveal that preemptive analgesia 
should focus on the prevention of central sensitization 
Table 4 Frequency of adverse events
Preemptive 
(n=23)
Control 
(n=24)
P-value
POnV 11 (47.8) 9 (37.5) 0.474
Temporary 
discontinuation of PCA
3 (13.0) 1 (4.2) 0.348
Urinary retention 4 (17.4) 1 (4.2) 0.188
Transient motor 
blockade
1 (4.3) 3 (12.5) 0.609
headache 1 (4.3) 0 (0.0) 0.489
Note: Data are presented as number of patients (%).
Abbreviations: PCA, patient-controlled analgesia; PONV, postoperative 
nausea and vomiting.
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along with the blockade of afferent nociceptive inputs. In 
this context, it would be interesting to study the efficacy 
of preemptive analgesia for this patient population using 
an N-methyl-d-aspartate receptor antagonist, which could 
attenuate central sensitization as a supplement to intraop-
erative epidural infusion of local anesthetic.30 In addition, 
multimodal analgesia is regarded as the most successful and 
powerful method to improve outcomes after surgery.31 In a 
recent animal study about multimodal preemptive analgesic 
strategy, the addition of preemptive ketamine–lidocaine 
infusion to single intravenous dose of tramadol enhanced the 
attenuation of central sensitization and improved intraopera-
tive and postoperative analgesia in dogs undergoing ovario-
hysterectomy.32 Therefore, our results suggest that preemptive 
analgesia should be included in multimodal analgesia rather 
than as a single method.
Conclusion
Intraoperative epidural infusion of ropivacaine in pediatric 
patients undergoing major orthopedic surgery of the lower 
extremities reduced pain scores only up to 6 hours post-
operatively and not thereafter. Additionally, postoperative 
analgesic consumption during 48 hours postoperatively 
was not significantly different between groups. This lack of 
preemptive analgesic efficacy emphasizes the importance of 
multimodal analgesia for this patient population.
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